Chemotherapy plus bevacizumab as an optimal first-line therapeutic treatment for patients with right-sided metastatic colon cancer: a meta-analysis of first-line clinical trials.

ESMO Open
Xia-Hong YouHou-Qun Ying

Abstract

Monoclonal antibodies of anti-epidermal growth factor receptor (EGFR) have been recommended as first-line therapy for patients with left-sided metastatic colorectal cancer (mCRC) with wild-type RAS. The effect of tumour laterality on antivascular endothelial growth factor antibody and how to optimise targeted therapies for the right-sided cases remain controversial. A comprehensive meta-analysis enrolling 16 first-line clinical trials was performed to evaluate the efficacy of chemotherapy alone and chemotherapy plus targeted therapies for patients with mCRC with right primary tumour site, and we validated the results in metastatic setting (14 trials containing 4306 patients with unresectable mCRC). Here, we found that progression-free survival (PFS) (combined HR 1.30, 95% CI 1.17 to 1.44) and overall survival (OS) (combined HR 1.46, 95% CI 1.32 to 1.62) of the right-sided patients were significantly inferior to the left-sided individuals receiving chemotherapy alone in overall population, regardless of race. Similar results were also observed in metastatic setting. OS of patients with left-sided mCRC receiving chemotherapy plus bevacizumab was superior to the right-sided individuals (combined median survival ratio (MSR)=1.23, 9...Continue Reading

References

Oct 6, 1997·BMJ : British Medical Journal·M EggerC Minder
Apr 29, 2005·Annals of Oncology : Official Journal of the European Society for Medical Oncology·F V NegriP J Ross
Jul 22, 2009·PLoS Medicine·David MoherUNKNOWN PRISMA Group
Jul 29, 2009·Nature Reviews. Clinical Oncology·Nicola NormannoFortunato Ciardiello
Feb 24, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Chiara CremoliniAlfredo Falcone
Jul 20, 2012·Nature·UNKNOWN Cancer Genome Atlas Network
Aug 29, 2012·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·F FerrandM Ducreux
Jul 25, 2014·Annals of Oncology : Official Journal of the European Society for Medical Oncology·E MissiagliaS Tejpar
Feb 26, 2015·Journal of the National Cancer Institute·Fotios LoupakisHeinz-Josef Lenz
Apr 30, 2015·Journal of Surgical Oncology·Yuan-Tzu LanShih-Ching Chang
Mar 14, 2016·Trends in Molecular Medicine·Stephen K H Li, Alberto Martin
Aug 11, 2016·International Journal of Cancer. Journal International Du Cancer·Yayoi TakahashiHiromu Suzuki
Nov 1, 2016·Nature Medicine·Sophia FrentzasAndrew R Reynolds
Dec 3, 2016·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Julian Walter HolchVolker Heinemann
Jan 9, 2017·Clinical Colorectal Cancer·Alexandra Khichfy AlexRachel P Riechelmann
Jan 18, 2017·Nature Reviews. Clinical Oncology·Chiara CremoliniAlfredo Falcone
Jun 10, 2017·International Journal of Molecular Sciences·Paola UliviAlessandro Passardi
Jun 11, 2017·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·R GaoH Qin
Aug 9, 2017·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Sebastian StintzingHeinz-Josef Lenz
Aug 11, 2017·Therapeutic Advances in Medical Oncology·Jonathan M Loree, Scott Kopetz
Dec 28, 2017·Critical Reviews in Oncology/hematology·Nele BoeckxKen Op de Beeck
Apr 4, 2018·The Lancet Oncology·David H Ilson
Apr 11, 2018·Journal of the National Comprehensive Cancer Network : JNCCN·Al B BensonDeborah A Freedman-Cass
May 24, 2018·Drugs·Claire GalloisJulien Taieb
May 29, 2018·Cytokine·Malgorzata Krzystek-KorpackaAndrzej Gamian
Jun 7, 2018·Annals of Oncology : Official Journal of the European Society for Medical Oncology·C CremoliniA Falcone
Feb 5, 2019·Clinical Colorectal Cancer·Gonzalo Tapia RicoAmanda Townsend

❮ Previous
Next ❯

Clinical Trials Mentioned

NCT01311050
NCT01282658

Software Mentioned

SPSS
Stata

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.